CIGNA Corp (CI)

2008 eps: 3.42 p/e 8.14
2009 eps: 3.85 p/e 7.2
2010 eps: 4.13 p/e 6.7

The valuation based on future ernings looks solid

re-up

fool

I'm looking for a weak managed health care company to give the thumbs down to and this may be it.

I have liquidity concerns for this company in the near-term and pricing concerns in the longer term.

A government sponsored (and subsidized) alternative HMO offering should really hurt this company's pricing and their sequential revenue is already weakening.

On the credit side, they are barely investment grade and their bond yields are pretty rich for a managed health organization which I'm taking as a signal of weakness.

Their dividend is anemic and they've already cut share buybacks out so that's signalling that they may not longer be able to support their own stock price through share buybacks.

Lastly, they are headquartered in Philadelphia and I have a general issue with the ethics of the business community in the greater Philadelphia area. That city has been the flashpoint for numerous business scandals that I'm aware of with Adelphia being the largest that comes to mind, but there are others. Must be something in the water (or possibly the sharing of book cooking techniques around the lockerrooms of the executive health clubs).

Thumbs down to Cigna!

PEG = 0.48

Healthcare insurance. Strong medicare/medicade fundamentals. When commercial membership increases so will the stock.

Earnings came in good, ADX and MACD are trending upwards.

I work in Healthcare and business is booming

CI IS ONE OF THE HEALTH COMPANIES THAT I AM WATCHING TO BUY IN MID 09. I WILL LET ALL FOOLS KNOW WHICH ONE I BUY

Has now joined s&p 500 12/11/2008

Health care .America Big bucks.

Stock will rise around 7% and level off because of elective surg decline.

Re-entering long on CIGNA; believe variable annuity business is manageable while health care and overall pension business remains attractive for the longer-term

will see small gain 3-4%

tech and future demands

least earnings exposure to potential margin downside from the commercial underwriting cycle

Solid cash flows. US Healthcare system isn't going to change anytime soon. Good management team.

With risk of a Dem in office next year, and baby boomers becoming more proactive in their health, expect this stock to stay downward this year. But up as more and more baby boomers age.

Is an investor-owned health service organization in the United States. The CompanyGÇÖs subsidiaries are providers of healthcare and related benefits, the majority of which are offered through the workplace, including healthcare products and services; group disability, life and accident insurance, and workersGÇÖ compensation case management and related services. CIGNAGÇÖs revenues are derived principally from premiums, fees, mail order pharmacy, other revenues and investment income. The Company operates in five business segments: HealthCare; Disability and Life; International; Other Operations, and Run-off Reinsurance. 26,600 Employees.

52 Week High 57.61
52 Week Low 36.75
Volume 1.94 Mil
Average Daily Volume (13wk) 1.02 Mil
50 Day Moving Average 47.08
200 Day Moving Average 50.93
Volatility (beta) 1.52

as people in early thirties boom in population, there is more need in what this company do.
their profit will increase dramatically